Type 1 diabetes patients on glucagon show increased satiety

08/22/2013 | Healio

A study in The Journal of Clinical Endocrinology & Metabolism revealed glucagon helped increase satiety in patients with type 1 diabetes and healthy lean participants. However, obese but otherwise healthy participants did not attain such benefits. Researchers said that while therapeutic agents that affect glucagon are considered "a promising avenue for research," the study indicates that treatment with glucagon might not be effective for reducing food consumption in obese people.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA